Tigreat

Tigreat (frovatriptan succinate monohydrate) is an oral triptan medication used for acute migraine relief. It belongs to a class of drugs that help narrow blood vessels in the brain. This product is manufactured by Menarini International Operations Luxembourg S.A. and is available for oral use.

Frovatriptan succinate monohydrate is primarily used to treat acute migraine headaches in adults. It helps reduce symptoms such as headache pain, nausea, and sensitivity to light and sound. This medication is not intended for preventive migraine treatment but is designed to provide relief during an active migraine episode. It works by targeting serotonin receptors to constrict blood vessels in the brain.

When taken as directed, frovatriptan succinate monohydrate can help alleviate migraine symptoms, including throbbing pain and associated discomfort. Users may experience a reduction in nausea and light sensitivity, allowing for improved daily functioning. The onset of relief varies by individual, with some noticing effects within a few hours.

Store frovatriptan succinate monohydrate at room temperature, away from moisture and heat. Keep this medication out of reach of children and pets. Avoid exposing it to extreme temperatures or direct sunlight. If the product shows signs of discoloration or damage, do not use it. Always check the expiration date before use.

Frovatriptan succinate monohydrate may interact with other medications, particularly those affecting serotonin levels, such as certain antidepressants or other migraine treatments. Alcohol consumption should be avoided while using this medication, as it may increase the risk of side effects. Consult a healthcare provider if you are taking other prescription or over-the-counter drugs.